Emma K Ellis

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Regulatory T Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Lobna A Elsadek, Emma K Ellis, Gustavo de Miranda Seabra, Valerie J Paul, Hendrik Luesch
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. Marine drugs 22 (1) (2023)
Lobna A Elsadek, Emma K Ellis, Gustavo de Miranda Seabra, Valerie J Paul, Hendrik Luesch
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. Marine drugs 22 (1) (2023)
Lobna A Elsadek, Emma K Ellis, Gustavo de Miranda Seabra, Valerie J Paul, Hendrik Luesch
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. Marine drugs 22 (1) (2023)
Lobna A Elsadek, Emma K Ellis, Gustavo de Miranda Seabra, Valerie J Paul, Hendrik Luesch
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. Marine drugs 22 (1) (2023)
Lobna A Elsadek, Emma K Ellis, Gustavo de Miranda Seabra, Valerie J Paul, Hendrik Luesch
Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity. Marine drugs 22 (1) (2023)